Top Story

HBV found to mature infant immune systems

March 31, 2015

Hepatitis B virus infection boosted immune system maturation among a cohort of infants in Singapore, according to newly published data in Nature Communications.

“Our work contributes to the understanding of how HBV exposure before birth shapes the global immune response of newborn infants and transforms the way we look at HBV,” Michelle Hong, research fellow at Duke-NUS Graduate Medical School, Singapore,  said in a press release. “Despite causing diseases later in life, HBV might actually be beneficial to humans early in life.”

In the Journals

Healthy changes to microbiome persist after FMT for C. difficile infection

March 31, 2015
Patients who underwent fecal microbiota transplantation for Clostridium difficile infection had healthy, dynamic short- and long-term changes to their microbiome…
Meeting News Coverage

U.K. residents swimming in coastal waters may ingest resistant E. coli

March 31, 2015
United Kingdom residents who use coastal waters recreationally could be exposed to antibiotic resistant Escherichia coli, according to data presented at the General …
In the Journals

Testing, antivirals underutilized in older adults with suspected influenza

March 31, 2015
The use of antivirals was low among older adults hospitalized with the suspected virus in urban Tennessee, despite recommendations for the early initiation of these…
Michael Boeckh In the Journals

Antivirals improve CMV pneumonia outcomes after HCT

March 30, 2015
Outcomes of cytomegalovirus pneumonia after hematopoietic cell transplantation have improved modestly over the past 25 years largely due to antiviral treatment and…
More News Headlines »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
Meeting News Coverage Video
thumbnail for video 4129869191001

Video: NIAID Ebola vaccine well tolerated, immunogenic

March 23, 2015
WILMINGTON, Del. — Julie Ledgerwood, DO, of the National Institute of Allergy and Infectious Diseases' Vaccine…
More »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
morganatic-roan